Owners, management and financials
CVR: 43952633
Secondary names: KinexaPharmaceuticals ApS, KinexaPharm ApS
DKK -129,726
Gross profit
Net result: DKK -56,425
MEVA HOLDING ApS (33,33-49,99%), CORIS Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Rune Risgaard, Lars Jørgensen
1 more in management
CVR · view management
Active
Founded 28 March 2023
CVR · view overview
0 employees
Annual report 2025 · average
Director registered: Mikkel Bender
CVR · 28/03/2023
View the full event history
KinexaTherapeutics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Rune Risgaard, Lars Jørgensen and Mikkel Bender. The company is owned by MEVA HOLDING ApS, CORIS Holding ApS and LAJOVI Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,726 and a net result of DKK -56,425 compared with DKK -286,245 the year before. Equity in the 2025 report amounted to DKK -315,170.
Selskabets formål er at drive virksomhed relateret til lægemiddelforskning samt anden, efter direktionens skøn, beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -130 t. | -56 t. | 146 t. | -315 t. | 0 | |
| 202401/01/2024 – 31/12/2024 | -276 t. | -286 t. | 67 t. | -259 t. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of KinexaTherapeutics ApS is 43952633.
KinexaTherapeutics ApS is owned by MEVA HOLDING ApS, CORIS Holding ApS and LAJOVI Holding ApS.
The management of KinexaTherapeutics ApS consists of Rune Risgaard, Lars Jørgensen and Mikkel Bender.
In 2025, KinexaTherapeutics ApS reported a gross profit of DKK -129,726.
KinexaTherapeutics ApS had an average of 0 employees in the 2025 financial year according to the annual report.
KinexaTherapeutics ApS was founded on 28 March 2023.
Claim this page to add your logo and social links. Free to get started.
KinexaTherapeutics ApS has published its annual report for 2025. Gross profit came to DKK -129,726, and the net result was DKK -56,425.
KinexaTherapeutics ApS has published its annual report for 2024. Gross profit came to DKK -276,347, and the net result was DKK -286,245.
KinexaTherapeutics ApS has published its interim report for the period March 28, 2023 – December 31, 2023.
As of March 28, 2023, Mikkel Bender is registered as director of KinexaTherapeutics ApS.
As of March 28, 2023, Rune Risgaard is registered as adm. dir. of KinexaTherapeutics ApS.
As of March 28, 2023, Lars Jørgensen is registered as director of KinexaTherapeutics ApS.
As of March 28, 2023, MEVA HOLDING ApS is registered as an owner of KinexaTherapeutics ApS with an ownership share of 33%.
As of March 28, 2023, CORIS Holding ApS is registered as an owner of KinexaTherapeutics ApS with an ownership share of 33%.
As of March 28, 2023, LAJOVI Holding ApS is registered as an owner of KinexaTherapeutics ApS with an ownership share of 33%.
KinexaTherapeutics ApS was founded on March 28, 2023.
Companies in the same industry and area
CVR 39330784
CVR 26333210
CVR 26392861
CVR 41366044
CVR 27701396
